SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-00-003395
Filing Date
2000-02-01
Accepted
2000-02-01 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 19533
  Complete submission text file 0000912057-00-003395.txt   21503
Mailing Address 333 PROVIDENCE HIGHWAY NORWOOD MA 02062
Business Address 333 PROVIDENCE HIGHWAY NORWOOD MA 02062 6176619312
IMMUNOGEN INC (Subject) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-40774 | Film No.: 519429
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice